FIELD: medicine.
SUBSTANCE: before and after treatment of ischemic heart disease modified LP (a) are determined by processing 0.6 ml of blood serum with 0.2 ml of 0.1% Triton X-100 solution, incubation for 15 minutes at 20°C, mixing of mixture by method of shaking for 120 times per min, with further addition of 7% solution of polyethylene glycol 6000 solution, incubation with Sudan B dye at 40°C for 1 h with further electrophoretic separation of LP in agarose gel in 4x20 mm hollow. If level of modified LP (a) reduces by 35% and level of HDLP in blood grows from 13% to 28% and more in comparison with initial level, treatment of ischemic heart disease is estimated as efficient.
EFFECT: application of claimed method makes it possible to determine additional minor fraction of modified blood LP and HDLP in dynamics, which increases accuracy of estimating efficiency of ischemic heart disease treatment.
6 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ESTIMATING CLINICAL EFFECTIVENESS IN CHRONIC HEART DISEASE | 2009 |
|
RU2396567C1 |
METHOD FOR ESTIMATING CLINICAL EFFECTIVENESS OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2462722C1 |
METHOD OF PREDICTING ISCHEMIC HEART DISEASE COURSE | 2010 |
|
RU2439582C1 |
METHOD OF PREDICTING COURSE OF CORONARY HEART DISEASE | 2009 |
|
RU2398239C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF ISCHEMIC HEART DISEASE | 2012 |
|
RU2507518C1 |
METHOD OF PREDICTING COURSE OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2470294C1 |
METHOD OF DETERMINING FRACTIONS OF MODIFIED LIPOPROTEINS IN BLOOD | 2009 |
|
RU2413952C2 |
METHOD OF FRACTION TEST OF MODIFIED BLOOD LIPOPROTEINS | 2010 |
|
RU2428698C1 |
METHOD OF FRACTIONAL ANALYSIS OF MODIFIED BLOOD LIPOPROTEINS | 2007 |
|
RU2364873C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF ISCHEMIC HEART DISEASE | 2012 |
|
RU2520755C1 |
Authors
Dates
2012-01-10—Published
2010-06-11—Filed